Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?: Epicutaneous allergen immunotherapy
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
IgE-mediated allergies, such as allergic rhinoconjunctivitis and asthma, have become highly prevalent, today affecting up to 30% of the population in industrialized countries. Allergen-specific immunotherapy (SIT) either subcutaneously or via the sublingual route is effective, but only few patients (<5%) choose immunotherapy, as treatment takes several years and because allergen administrations are associated with local and, in some cases, even systemic allergic side-effects because of allergen accidentally reaching the circulation. In order to resolve these two major drawbacks, the ideal application site of SIT should have two characteristics. First, it should contain a high number of potent antigen-presenting cells to enhance efficacy and shorten treatment duration. Secondly, it should be nonvascularized in order to minimize inadvertent systemic distribution of the allergen and therefore systemic allergic side-effects. The epidermis, a nonvascularized multilayer epithelium, that contains high numbers of potent antigen-presenting Langerhans cells (LC) could therefore be an interesting administration route. The present review will discuss the immunological rational, history and actual clinical experience with epicutaneous allergen-specific immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887 · cited 2×
“Alum not only increased the immunogenicity of the vaccine but also reduced the risk of systemic allergic side-effects because of its depot effect at the injection site (10).”
BackgroundOrigin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells
Merad, M., Ginhoux, F., & Collin, M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2455 · Cited by 850 · cited 2×
“In contrast to the epidermis, the dermis harbours a great diversity of cell types ranging from fibroblasts to macrophages, mast cells, different subsets of dermal dendritic cells (DCs) (22) as well as T cells (19).”
BackgroundSenti, G., Prinz Vavricka, B. M., Erdmann, I., Diaz, M. I., Markus, R., McCormack, S. J., Simard, J. J., Wüthrich, B., Crameri, R., Graf, N., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803725105 · Cited by 364
Self-citationEpicutaneous allergen administration as a novel method of allergen-specific immunotherapy
Senti, G., Graf, N., Haug, S., Rüedi, N., von Moos, S., Sonderegger, T., Johansen, P., & Kündig, T. M. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.07.019 · Cited by 203
Self-citationRELIEF OF HAY-FEVER BY INTRADERMAL INJECTIONS OF POLLEN EXTRACT
PHILLIPS, E. W. (1926) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1926.02670290022008 · Cited by 50 · cited 3×
“Phillips (56) started to treat very sensitive patients as well as those desiring co-seasonal treatment by the administration of pollen extract ‘into the substance of the skin, the same as an intradermal test.”
BackgroundMethodInfluential
Cited by
Akdis (2020) · doi:10.1111/pai.13189 · Cited by 320
Senti, G., von Moos, S., Tay, F., Graf, N., Sonderegger, T., Johansen, P., & Kündig, T. M. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.08.036 · Cited by 158
Self-citationDermAll nanomedicine for allergen-specific immunotherapy
Garaczi, E., Szabó, K., Francziszti, L., Csiszovszki, Z., Lőrincz, O., Tőke, E. R., Molnár, L., Bitai, T., Jánossy, T., Bata-Csörgő, Z., et al. (2013) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2013.05.011 · Cited by 12
Metadata
- Authors
- Senti, G., von Moos, S., & Kündig, T. M.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2011-02-24
- Volume
- 66
- Issue
- 6
- Pages
- 798-809
- ISSN
- 0105-4538 (ISSN-L)
- OpenAlex
- W1601801276
- Cited by
- 65
- References
- 5
- FWCI
- 5.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?: Epicutaneous allergen immunotherapy. https://app.cochat.ai/papers/10.1111/j.1398-9995.2011.02560.x
- The paper
- Senti, G., von Moos, S., & Kündig, T. M. (2011). Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?: Epicutaneous allergen immunotherapy. Allergy. https://doi.org/10.1111/j.1398-9995.2011.02560.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.